Paper29045232
Imaging Neoadjuvant Therapy Response in Breast Cancer.
Fowler AM and 2 others. Radiology, 2017. Cited by 189 papers, by iCite.
Cite this record
ConductScience Library. Imaging Neoadjuvant Therapy Response in Breast Cancer. Papers, record 29045232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29045232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast | Major topic |
| Breast Neoplasms | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Molecular Imaging | Major topic |
| Positron Emission Tomography Computed Tomography | Major topic |
| Aged | |
| Contrast Media | |
| Female | |
| Humans | |
| Middle Aged | |
| Neoadjuvant Therapy |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05951699 | Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy | Results |
Source ClinicalTrials.gov
Cited by133
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 189 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42807117 | Modelling image quality over extended [18F]FDG uptake times for low-dose positron emission mammography. | Front Oncol | 2026 | https://conductscience.org/library/papers/42807117 | PubMed |
| 42699276 | Performance of MRI-based deep learning models in differentiation of triple negative breast cancer from other breast cancer subtypes: A systematic review and meta-analysis. | Eur J Radiol Open | 2026 | https://conductscience.org/library/papers/42699276 | PubMed |
| 42661023 | On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42661023 | PubMed |
| 42562610 | 68Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study. | J Nucl Med | 2026 | https://conductscience.org/library/papers/42562610 | PubMed |
| 42421849 | Gramado consensus on imaging evaluation of the response to neoadjuvant systemic therapy for breast cancer. | Radiol Bras | 2026 | https://conductscience.org/library/papers/42421849 | PubMed |
| 42358985 | Early identification of neoadjuvant therapy non-response via multimodal immune-imaging biomarkers in breast cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42358985 | PubMed |
| 42211537 | The Neoadjuvant Approach to Treatment of Breast Cancer: Multidisciplinary Management to Improve Outcomes. | Surg Oncol Insight | 2024 | https://conductscience.org/library/papers/42211537 | PubMed |
| 42194721 | Baseline and Early-Delta Quantitative Ultrasound Radiomics for Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer. | J Clin Med | 2026 | https://conductscience.org/library/papers/42194721 | PubMed |
| 42137125 | Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients. | Gastroenterol Hepatol Bed Bench | 2025 | https://conductscience.org/library/papers/42137125 | PubMed |
| 41972087 | Optimizing abbreviated breast MRI protocols for the early assessment of neoadjuvant chemotherapy response in breast cancer. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/41972087 | PubMed |
| 41695376 | Early peritumoral edema change improve prediction of pathological complete response in breast cancer: a multiparametric magnetic resonance imaging-based model. | Front Oncol | 2026 | https://conductscience.org/library/papers/41695376 | PubMed |
| 41576341 | Identification and Localization of Breast Tumor Components via a Convolutional Neural Network Based on High-Frequency Ultrasound Combined With Histopathologic Registration: Prospective Study. | JMIR Med Inform | 2026 | https://conductscience.org/library/papers/41576341 | PubMed |
| 41543378 | From Voxel-wise Fitting to Generative Translation: A Path for Quantitative DCE MRI Analysis in Breast Cancer. | Radiol Imaging Cancer | 2026 | https://conductscience.org/library/papers/41543378 | PubMed |
| 41536974 | Dual-input spatio-temporal transformer model: Predicting the efficacy of NACT in breast cancer based on DCE-MRI images. | iScience | 2026 | https://conductscience.org/library/papers/41536974 | PubMed |
| 41352211 | Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping review. | Breast | 2026 | https://conductscience.org/library/papers/41352211 | PubMed |
| 41333210 | Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world setting and development of a predictive model for pathological complete response. | Front Oncol | 2025 | https://conductscience.org/library/papers/41333210 | PubMed |
| 41301040 | The Role of Quantitative Ultrasound in Monitoring Neoadjuvant Chemotherapy in Breast Cancer: A Narrative Review. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41301040 | PubMed |
| 41104977 | Elastography and MRI for the Evaluation of Complete Response to Neoadjuvant Therapy for Breast Cancer. | Radiol Imaging Cancer | 2025 | https://conductscience.org/library/papers/41104977 | PubMed |
| 40977301 | Early prediction of neoadjuvant chemotherapy efficacy among patients with triple-negative breast cancer using an ultrasound-based radiomics nomogram. | Diagn Interv Radiol | 2025 | https://conductscience.org/library/papers/40977301 | PubMed |
| 40775094 | Can we cut the contrast? DWI shows similar value to standard MRI for assessing treatment response in breast cancer. | Eur Radiol | 2025 | https://conductscience.org/library/papers/40775094 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29045232
GET https://conductscience.org/api/papers/v1/29045232/cited_by?page=2